endocrine disorders and management final

Upload: eniryz-m-salomon

Post on 08-Jul-2018

216 views

Category:

Documents


7 download

TRANSCRIPT

  • 8/19/2019 Endocrine Disorders and Management Final

    1/76

    01/26/16

    Prepared by: Zyrine M. Salomon,R.N

    Assessment and Management of

    Patients with Endocrine Disorders

    1

  • 8/19/2019 Endocrine Disorders and Management Final

    2/76

  • 8/19/2019 Endocrine Disorders and Management Final

    3/76

    Definition of HormonesChemical messengers of the body

    Act on specific target cells

    Regulated by negatie feedbac! 

    "oo much hormone, then hormone release reduced

    "oo little hormone, then hormone release increased

    01/26/20163

  • 8/19/2019 Endocrine Disorders and Management Final

    4/76

    #ypothalamus

    Posterior Pituitary

    Anterior Pituitary

    "hyroid

    Parathyroids

    Adrenals

    Pancreatic islets

    $aries and testes

    01/26/2016

    Glands of the Endocrine

    System

    4

  • 8/19/2019 Endocrine Disorders and Management Final

    5/76

    Hypothalamus

    Sits bet%een the cerebrum and brainstem

    #ouses the pituitary gland and hypothalamus

    Regulates:

    "emperature&luid olume

    'ro%th

    Pain and pleasure response#unger and thirst

    01/26/20165

  • 8/19/2019 Endocrine Disorders and Management Final

    6/76

    01/26/2016

    Hypothalamus Hormones

    Releasing and inhibiting hormones

    Corticotropin(releasing hormone

    "hyrotropin(releasing hormone

    'ro%th hormone(releasing hormone

    'onadotropin(releasing hormone

    Somatostatin()(inhibits '# and "S#

    6

  • 8/19/2019 Endocrine Disorders and Management Final

    7/76

    Pituitary Gland

    Sits beneath the hypothalamus

    "ermed the *master gland+

    iided into:

    Anterior Pituitary 'landPosterior Pituitary 'land

    01/26/20167

  • 8/19/2019 Endocrine Disorders and Management Final

    8/76

    01/26/2016

    Anterior Pituitary Gland

    Promotes gro%th

    Stimulates the secretion of si- hormones

    Controls pigmentation of the s!in

    8

  • 8/19/2019 Endocrine Disorders and Management Final

    9/76

    01/26/2016

    Anterior Pituitary Gland

    Hormones

    'ro%th #ormone((Adrenocorticotropic hormone

    "hyroid stimulating hormone

    &ollicle stimulating hormoneoary in female,

    sperm in males

    /uteini0ing hormonecorpus luteum in females,

    secretion of testosterone in males

    Prolactinprepares female breasts for lactation

    9

  • 8/19/2019 Endocrine Disorders and Management Final

    10/76

    Actions of the major hormones of the anterior pituitary.

    01/26/201610

  • 8/19/2019 Endocrine Disorders and Management Final

    11/76

    01/26/2016

    Posterior Pituitary Hormones

    Antidiuretic #ormone

    $-ytocincontraction of uterus, mil! e1ection

    from breasts

    11

  • 8/19/2019 Endocrine Disorders and Management Final

    12/76

    01/26/2016

    Adrenal orte!

    Mineralocorticoidaldosterone. Affects sodium

    absorption, loss of potassium by !idney

    'lucocorticoidscortisol. Affects metabolism,regulates blood sugar leels, affects gro%th, anti(

    inflammatory action, decreases effects of stress

    Adrenal androgensdehydroepiandrosterone and

    androstenedione. Conerted to testosterone in the

    periphery.

    12

  • 8/19/2019 Endocrine Disorders and Management Final

    13/76

    01/26/2016

    Adrenal Medulla

    2pinephrine and norepinephrine

    sere as neurotransmitters for sympathetic system

    13

  • 8/19/2019 Endocrine Disorders and Management Final

    14/76

    29/11/201014

  • 8/19/2019 Endocrine Disorders and Management Final

    15/76

    01/26/2016

    "hyroid Gland

    3utterfly shaped

    Sits on either side of the trachea

    #as t%o lobes connected %ith an isthmus

    &unctions in the presence of iodineStimulates the secretion of three hormones

    4noled %ith metabolic rate management and

    serum calcium leels

    15

  • 8/19/2019 Endocrine Disorders and Management Final

    16/76

    01/26/2016

    "hyroid

    &ollicular cells e-cretion of triiodothyronine 5"67and thyro-ine 5"874ncrease 3MR, increase bone

    and calcium turnoer, increase response to

    catecholamines, need for fetal '9

    "hyroid C cellscalcitonin. /o%ers blood calcium

    and phosphate leels

    3MR: 3asal Metabolic Rate

    16

  • 8/19/2019 Endocrine Disorders and Management Final

    17/76

    Parathyroid Glands

    2mbedded %ithin the posterior lobes of the thyroidgland

    Secretion of one hormone

    Maintenance of serum calcium leels

    01/26/201617

  • 8/19/2019 Endocrine Disorders and Management Final

    18/76

  • 8/19/2019 Endocrine Disorders and Management Final

    19/76

    Pancreas

    /ocated behind the stomach bet%een the spleenand duodenum

    #as t%o ma1or functions

    igestie en0ymes

    Releases t%o hormones: insulin and glucagon

    01/26/201619

  • 8/19/2019 Endocrine Disorders and Management Final

    20/76

    01/26/2016

    Pancreatic Hormones

    4nsulin ( a hormone made by the pancreas that allo%s your body touse sugar 5glucose7 from carbohydrates in the food that you eat for

    energy or to store glucose for future use. 4nsulin helps !eeps your

    blood sugar leel from getting too high 5hyperglycemia7 or too lo%

    5hypoglycemia7.

    'lucagon stimulates glycogenolysis and

    glyconeogenesis

    Somatostatin decreases intestinal absorption of

    glucose

    20

  • 8/19/2019 Endocrine Disorders and Management Final

    21/76

    #nsulin

    Produced by the 3eta cells in the islets of/angerhans

    Regulates blood glucose leels

    Mechanisms

    2ases the actie transport of glucose into muscle and

    fat cells

    &acilitates fat formation

    4nhibits the brea!do%n and moement of stored fat

    #elps %ith protein synthesis

    01/26/201621

  • 8/19/2019 Endocrine Disorders and Management Final

    22/76

  • 8/19/2019 Endocrine Disorders and Management Final

    23/76

    (continued' Action of insulin and glucagon on $lood glucose le%els. &(' Low $lood

    glucose is raised $y glucagon release.

    01/26/20623

  • 8/19/2019 Endocrine Disorders and Management Final

    24/76

    Glucagon

    Produced by the alpha cells in the islets of /angerhans

    'lucagon released %hen blood glucose falls belo% ;

    mg

  • 8/19/2019 Endocrine Disorders and Management Final

    25/76

    Glucagon

    Preents blood glucose from decreasing belo% acertain leel

    &unctions:

    Ma!es ne% glucose

    Conerts glycogen into glucose in the lier and

    muscles

    Preents e-cess glucose brea!do%n

    ecreases glucose o-idation and increases blood

    glucose

    01/26/201625

  • 8/19/2019 Endocrine Disorders and Management Final

    26/76

    Adrenal Glands

    Pyramid(shaped organs that sit on top of the!idneys

    2ach has t%o parts:

    $uter Corte-

    4nner Medulla

    01/26/201626

  • 8/19/2019 Endocrine Disorders and Management Final

    27/76

    Adrenal orte!

    Secretion of t%o hormones'lucocorticoids: cortisol

    Mineralocortocoids: aldosterone

    4noled %ith blood glucose leel, anti(

    inflammatory response, blood olume, and

    electrolyte maintenance

    01/26/201627

  • 8/19/2019 Endocrine Disorders and Management Final

    28/76

    Adrenal Medulla

    Secretion of t%o hormones

    2pinephrine

    Norepinephrine

    4noled %ith the stress response

    01/26/201628

  • 8/19/2019 Endocrine Disorders and Management Final

    29/76

    01/26/2016

    )%aries

    2strogenProgesteroneinportant in menstrual

    cycle,=maintains pregnancy,

    29

  • 8/19/2019 Endocrine Disorders and Management Final

    30/76

    01/26/2016

    "estes

    Androgens, testosteronesecondary se-ualcharacteristics, sperm production

    30

  • 8/19/2019 Endocrine Disorders and Management Final

    31/76

    29/11/2010

    "hymus

    Releases thymosin and thymopoietinAffects maturation of " lymphocetes

    31

  • 8/19/2019 Endocrine Disorders and Management Final

    32/76

    01/26/2016

    Pineal

    MelatoninAffects sleep, fertility and aging

    32

  • 8/19/2019 Endocrine Disorders and Management Final

    33/76

    01/26/2016

    Prostaglandins

    >or! locallyReleased by plasma cells

    Affect fertility, blood clotting, body temperature

    33

  • 8/19/2019 Endocrine Disorders and Management Final

    34/76

    01/26/1634

  • 8/19/2019 Endocrine Disorders and Management Final

    35/76

    01/262016

    35

  • 8/19/2019 Endocrine Disorders and Management Final

    36/76

    01/26/2016

    36

  • 8/19/2019 Endocrine Disorders and Management Final

    37/76

    01/26/201637

  • 8/19/2019 Endocrine Disorders and Management Final

    38/76

    01/26/2016

    38

  • 8/19/2019 Endocrine Disorders and Management Final

    39/76

  • 8/19/2019 Endocrine Disorders and Management Final

    40/76

    01/26/2016

    40

  • 8/19/2019 Endocrine Disorders and Management Final

    41/76

    01/26/2016

    41

  • 8/19/2019 Endocrine Disorders and Management Final

    42/76

    01/26/2016

    42

  • 8/19/2019 Endocrine Disorders and Management Final

    43/76

    29/11/201043

  • 8/19/2019 Endocrine Disorders and Management Final

    44/76

    M?@22MA C$MA

    occasionally called my!edema

    crisis* is a rare life+threatening

    clinical condition that represents

    se%ere hypothyroidism with

    physiological DE .compensation

    01/26/2016

    44

  • 8/19/2019 Endocrine Disorders and Management Final

    45/76

    The condition usually occurs inpatients with long-standing,undiagnosed hypothyroidism and isusually precipitated by infection,cerebrovascular disease, heart failure,trauma, or drug therapy. Patients withmyxedema coma are generallyseverely-ill with signicant

    hypothermia and depressed mentalstatus.

    M,-EDEMA )MA

    01/26/2016

    45

  • 8/19/2019 Endocrine Disorders and Management Final

    46/76

    MANAGEMENT:

    Air%ay management

    ( Mechanical ventilation is commonly required during

    the first 6!"# hours, $ut some %atients require

     %rolonged res%iratory su%%ort for as long as 2! &ee's.

    01/26/2016

    46

  • 8/19/2019 Endocrine Disorders and Management Final

    47/76

    01/26/2016

    47

  • 8/19/2019 Endocrine Disorders and Management Final

    48/76

    29/11/201048

  • 8/19/2019 Endocrine Disorders and Management Final

    49/76

    01/26/2016

    49

  • 8/19/2019 Endocrine Disorders and Management Final

    50/76

    01/26/201650

  • 8/19/2019 Endocrine Disorders and Management Final

    51/76

    01/26/201651

  • 8/19/2019 Endocrine Disorders and Management Final

    52/76

    01/26/2016

    52

  • 8/19/2019 Endocrine Disorders and Management Final

    53/76

    01/26/2016

    53

  • 8/19/2019 Endocrine Disorders and Management Final

    54/76

    29/11/201054

    ADRENAL CRISIS

  • 8/19/2019 Endocrine Disorders and Management Final

    55/76

     ADRENAL CRISIS

    also 'no&n as (ddisonian crisis and

    acute adrenal insufficiency, a medical

    emergency and %otentially life!threatening

    situation requiring immediate emergency

    treatment. )t is a constellation of sym%tomsthat indicate severe adrenal insufficiency

    caused $y insufficient levels of the hormone

    cortisol.

    01/26/2016

    55

  • 8/19/2019 Endocrine Disorders and Management Final

    56/76

    auses* incidence* and ris

    factors/(drenal crisis occurs if the adrenal gland is

    deteriorating *(ddison+s disease, %rimary adrenal

    insufficiency, if there is %ituitary gland in-ury

    *secondary adrenal insufficiency, or if adrenal

    insufficiency is not adequately treated.is' factors for adrenal crisis include %hysical stress

    such as infection, dehydration, trauma, or surgery,

    adrenal gland or %ituitary gland in-ury, and ending

    treatment &ith steroids such as %rednisone orhydrocortisone too early.

    01/26/2016

    56

  • 8/19/2019 Endocrine Disorders and Management Final

    57/76

    MANIFESTATIONS:eadache, Profound &ea'ness, atigue

    lo&, sluggish movement, ausea and 3omiting

    4o& $lood %ressure, 5ehydration

    igh fever, ha'ing chills, onfusion or coma

    a%id heart rate, 7oint %ain, ($dominal %ain

    8nintentional &eight loss

    a%id res%iratory rate *see tachy%nea

    8nusual and ecessive s&eating on face and/or %alms

    'in rash or lesions may $e %resent

    lan' %ain

    4oss of a%%etite

    01/26/2016

    57

  • 8/19/2019 Endocrine Disorders and Management Final

    58/76

  • 8/19/2019 Endocrine Disorders and Management Final

    59/76

    ;mergency Management for (ddisonian risisMaintain air&ay, $reathing, and circulation in %atients &ith

    adrenal crisis.

    8se coma %rotocol *ie, glucose, thiamine, naloone.

    8se aggressive volume re%lacement thera%y *detrose 5

  • 8/19/2019 Endocrine Disorders and Management Final

    60/76

    Emergency Management for Addisonian risis

    8se detrose

  • 8/19/2019 Endocrine Disorders and Management Final

    61/76

    Emergency Management for Addisonian risis

    Bnce the %atient sta$iliCes, usually $y the second day,

    the corticosteroid dose may $e reduced and thenta%ered. Bral maintenance can usually $e achieved $y

    the fourth or fifth day.

    (l&ays treat the underlying %ro$lem that %reci%itated

    the crisis. )nfectious etiologies commonly %reci%itateadrenal crisis. ecognition and treatment of causative

    factors are crucial as%ects of managing adrenal

    hy%ofunction.

    01/26/2016

    61

  • 8/19/2019 Endocrine Disorders and Management Final

    62/76

    29/11/201062

  • 8/19/2019 Endocrine Disorders and Management Final

    63/76

    ( t $l hi h i hi$it th ff t f d li

  • 8/19/2019 Endocrine Disorders and Management Final

    64/76

    01/26/201664

    • (eta $locers* which inhi$it the effect of adrenaline,

    re!"# $% &'!r e)r# *e)#$%+ 're "'-"& )%. -$# "e

    /'re e#) *"'er )"' e" ee *"''. ee" 'e%

    )%. re")e. *& "'-$%+ #e re"e)e '/ ) )r#$!")re%&e /r' $.%e& E)"e '/ *e#) *"'er $%"!.e

    )#e%'"'" (Te%'r$%, e#'r'"'" (L're'r, T'r'" )%.

    r'r)%'"'" (I%.er)", I%%'r)% S$.e e//e# )& $%"!.e

    /)#$+!e, !e# #'), e).)e, .$$%e,'%#$)#$'%, .$)rre), $rre+!")r e)r#*e)#, .$//$!"#&

    *re)#$%+ )%. -e""$%+ $% #e "$*

    • )ther medications #)# "'-er *"''. re!re )& *e

    rer$*e. $/ *"''. re!re $ %'# #)*$"$e. -$# )")*"'er )%. *e#) *"'er

    Surgery

  • 8/19/2019 Endocrine Disorders and Management Final

    65/76

    01/26/201665

    Surgery

    •#n most cases* the entire adrenal gland with a pheochromocytoma

    is remo%ed with laparoscopic* or minimally in%asi%e* surgery.

    Surgeon will mae a few small openings through which he or sheinserts wand+lie de%ices e4uipped with %ideo cameras and small

    tools.

    •"he remaining healthy adrenal gland carries out the functions

    normally performed $y two* and $lood pressure usually returns tonormal. #n some unusual situations* such as when the other

    adrenal gland has already $een remo%ed* a surgery may $e

    considered to e!tract only the tumor and spare some of the healthy

    tissue.

    •#f a tumor is cancerous &malignant'* surgery may $e effecti%e only

    if the tumor and any metastasi5ed tissues are isolated. Howe%er*

    e%en if all of the cancerous tissues are not remo%ed* surgery may

    limit hormone production and pro%ide some control of $lood

    pressure.

  • 8/19/2019 Endocrine Disorders and Management Final

    66/76

    29/11/201066

  • 8/19/2019 Endocrine Disorders and Management Final

    67/76

  • 8/19/2019 Endocrine Disorders and Management Final

    68/76

    01/26/201668

    ;ERGLCEMIA

  • 8/19/2019 Endocrine Disorders and Management Final

    69/76

    ;ERGLCEMIA

    a term referring to high blood glucose leels ( the

    condition that often leads to a diagnosis of diabetes.

    igh $lood glucose levels are the defining feature of

    dia$etes, $ut once the disease is diagnosed,

    hy%erglycemia is a signal of %oor control over the

    condition.

    y%erglycemia is defined $y certain high levels of $lood

    glucose@

    asting levels greater than A.0 mmol/4 *126 mg/d4

    :&o!hours %ost%randial *after a meal levels greater than

    11.0 mmol/4 *200 mg/d4.

    01/26/201669

    S t f h l

    i

  • 8/19/2019 Endocrine Disorders and Management Final

    70/76

    :hirst and hunger 

    5ry mouthrequent urination, %articularly at night

    :iredness

    ecurrent infections, such as thrush

    Eeight loss

    3ision $lurring.

    Symptoms of hyperglycemia/

    01/26/201670

    C / " $

  • 8/19/2019 Endocrine Disorders and Management Final

    71/76

    C)!e '/ &er+"&e$):

    ;ating more or eercising less than usual

    )nsufficient amount of insulin treatment *more

    commonly in cases of ty%e 1 dia$etes

    )nsulin resistance in ty%e 2 dia$etes

    Psychological and emotional stress:he Fda&n %henomenonF or Fda&n effectF ! an early

    morning hormone surge.

    29/11/201071

  • 8/19/2019 Endocrine Disorders and Management Final

    72/76

    Emergency treatment for se%ere

    hyperglycemia

    &luid replacement. (dminister fluids — either orally

    or through intravenously — until %atient is rehydrated.

    :he fluids re%lace those lost through ecessive

    urination, as &ell as hel% dilute the ecess sugar in the

     $lood.

    2lectrolyte replacement. ;lectrolytes are minerals in

    the $lood that are necessary for the tissues to function

     %ro%erly. :he a$sence of insulin can lo&er the level of

    several electrolytes in the $lood.

    01/26/201672

  • 8/19/2019 Endocrine Disorders and Management Final

    73/76

  • 8/19/2019 Endocrine Disorders and Management Final

    74/76

    01/26/2016

    Thank You !! 

    74

  • 8/19/2019 Endocrine Disorders and Management Final

    75/76

    Never Stop Learning,because life never

    stops teaching…- Zyrine Salomon  

    01/26/201675

  • 8/19/2019 Endocrine Disorders and Management Final

    76/76